David Chantry

6.6k total citations
74 papers, 5.5k citations indexed

About

David Chantry is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, David Chantry has authored 74 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 24 papers in Oncology and 11 papers in Immunology and Allergy. Recurrent topics in David Chantry's work include T-cell and B-cell Immunology (18 papers), Chemokine receptors and signaling (17 papers) and Immunotherapy and Immune Responses (15 papers). David Chantry is often cited by papers focused on T-cell and B-cell Immunology (18 papers), Chemokine receptors and signaling (17 papers) and Immunotherapy and Immune Responses (15 papers). David Chantry collaborates with scholars based in United States, United Kingdom and Italy. David Chantry's co-authors include Martin Turner, Marc Feldmann, Patrick W. Gray, Ronald Godiska, Ravinder N. Maini, Fionula M. Brennan, Carol J. Raport, Kathy Barrett, G.S. Buchan and Christi L. Wood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Chantry

74 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Chantry United States 35 3.0k 1.8k 1.1k 870 636 74 5.5k
Dagmar Scheel‐Toellner United Kingdom 35 2.5k 0.8× 1.0k 0.6× 1.9k 1.7× 930 1.1× 483 0.8× 63 5.4k
G. Kenneth Haines United States 43 2.3k 0.8× 2.2k 1.2× 2.1k 1.9× 1.6k 1.9× 1.1k 1.7× 92 6.6k
Pascale Chomarat France 27 2.9k 1.0× 1.1k 0.6× 1.0k 0.9× 623 0.7× 280 0.4× 32 4.8k
Jean‐François Gauchat Canada 39 3.4k 1.1× 833 0.5× 1.1k 1.0× 421 0.5× 706 1.1× 95 5.4k
T Hirano Japan 36 2.9k 1.0× 1.9k 1.1× 1.4k 1.2× 437 0.5× 338 0.5× 117 6.1k
B J Nickoloff United States 45 3.5k 1.2× 1.3k 0.7× 1.6k 1.4× 341 0.4× 976 1.5× 79 6.9k
Shixin Qin United States 37 6.4k 2.1× 2.9k 1.6× 1.2k 1.1× 598 0.7× 721 1.1× 49 9.1k
Glenn E. Nedwin United States 15 3.0k 1.0× 1.3k 0.7× 2.3k 2.1× 492 0.6× 412 0.6× 21 6.1k
A E Koch United States 33 2.7k 0.9× 2.4k 1.3× 1.5k 1.4× 1.7k 1.9× 1.5k 2.3× 47 6.5k
Nathan Karin Israel 35 3.3k 1.1× 1.7k 0.9× 1.0k 0.9× 451 0.5× 600 0.9× 62 5.2k

Countries citing papers authored by David Chantry

Since Specialization
Citations

This map shows the geographic impact of David Chantry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chantry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chantry more than expected).

Fields of papers citing papers by David Chantry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chantry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chantry. The network helps show where David Chantry may publish in the future.

Co-authorship network of co-authors of David Chantry

This figure shows the co-authorship network connecting the top 25 collaborators of David Chantry. A scholar is included among the top collaborators of David Chantry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chantry. David Chantry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Jim, Jacqueline Harrison, Karyn Bouhana, et al.. (2021). Abstract 1735: The potent and selective MERTK/AXL inhibitor PF-5807/ARRY-067 activates dendritic cells to cross-prime CD8+ T cells for anti-tumor activity. Cancer Research. 81(13_Supplement). 1735–1735. 6 indexed citations
2.
Wenzel, Sally E., David Chantry, Robert W. Hopkins, et al.. (2014). ARRY-502, a potent, selective, oral CRTh2 antagonist reduces Th2 mediators in patients with mild to moderate Th2-driven asthma. European Respiratory Journal. 44(Suppl 58). 4836–4836. 4 indexed citations
3.
Wenzel, Sally E., Robert W. Hopkins, Michael D. Saunders, et al.. (2014). Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma. Journal of Allergy and Clinical Immunology. 133(2). AB4–AB4. 14 indexed citations
4.
Cook, Adam, George Doherty, Kevin J. Hunt, et al.. (2009). Identification and characterization of a potent and selective antagonist of the prostaglandin D2 receptor (94.23). The Journal of Immunology. 182(Supplement_1). 94.23–94.23. 1 indexed citations
5.
Chantry, David. (2004). HIV entry and fusion inhibitors. Expert Opinion on Emerging Drugs. 9(1). 1–7. 8 indexed citations
6.
Kim, Soon H., et al.. (2002). CCR4-bearing T cells participate in autoimmune diabetes. Journal of Clinical Investigation. 110(11). 1675–1686. 2 indexed citations
7.
Read, Sue, et al.. (2001). Metaphor: exploring its origins and therapeutic use in death, dying and bereavement. International Journal of Palliative Nursing. 7(7). 345–353. 17 indexed citations
8.
Galli, Grazia, David Chantry, Francesco Annunziato, et al.. (2000). Macrophage-derived chemokine production by activated human T cellsin vitro andin vivo: preferential association with the production of type 2 cytokines. European Journal of Immunology. 30(1). 204–210. 93 indexed citations
9.
Stine, Johnny T., David Chantry, & Patrick W. Gray. (1999). Virally Encoded Chemokines and Chemokine Receptors: Genetic Embezzlement of Host DNA. PubMed. 72. 161–180. 7 indexed citations
10.
Imai, Toshio, David Chantry, Carol J. Raport, et al.. (1998). Macrophage-derived Chemokine Is a Functional Ligand for the CC Chemokine Receptor 4. Journal of Biological Chemistry. 273(3). 1764–1768. 320 indexed citations
11.
Godiska, Ronald, David Chantry, Carol J. Raport, et al.. (1997). Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells. The Journal of Experimental Medicine. 185(9). 1595–1604. 423 indexed citations
12.
Godiska, Ronald, David Chantry, Carol J. Raport, et al.. (1997). Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. Journal of Leukocyte Biology. 61(3). 353–360. 33 indexed citations
13.
Chantry, David, Anne B. Vojtek, Adam Kashishian, et al.. (1997). p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes. Journal of Biological Chemistry. 272(31). 19236–19241. 210 indexed citations
14.
Turner, Martin, et al.. (1991). Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β. European Journal of Immunology. 21(7). 1635–1639. 146 indexed citations
15.
Haworth, C, Fionula M. Brennan, David Chantry, et al.. (1991). Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α. European Journal of Immunology. 21(10). 2575–2579. 251 indexed citations
16.
Turner, Martin, David Chantry, & Marc Feldmann. (1990). Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine. 2(3). 211–216. 72 indexed citations
17.
Chantry, David, Martin Turner, Erika R. Abney, & Marc Feldmann. (1989). Modulation of cytokine production by transforming growth factor-beta.. The Journal of Immunology. 142(12). 4295–4300. 282 indexed citations
18.
Feldmann, Marc, G.S. Buchan, Fionula M. Brennan, et al.. (1988). Role of HLA Class II and Cytokine Expression in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 17(sup76). 39–46. 8 indexed citations
19.
Buchan, G.S., Kathy Barrett, Martin Turner, et al.. (1988). Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.. PubMed. 73(3). 449–55. 280 indexed citations
20.
Hooper, D. Craig, David Chantry, & W. D. Billington. (1987). Murine pregnancy-associated modulations in lymphocyte reactivity to mitogens: Identification of the cell populations affected. Journal of Reproductive Immunology. 11(4). 273–286. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dagmar Scheel‐Toellner Breakdown of academic impact, for papers by G. Kenneth Haines Breakdown of academic impact, for papers by Pascale Chomarat Breakdown of academic impact, for papers by Jean‐François Gauchat Breakdown of academic impact, for papers by T Hirano Breakdown of academic impact, for papers by B J Nickoloff Breakdown of academic impact, for papers by Shixin Qin Breakdown of academic impact, for papers by Glenn E. Nedwin Breakdown of academic impact, for papers by A E Koch Breakdown of academic impact, for papers by Nathan Karin
Rankless by CCL
2026